RecruitingNCT07525882

Effects of Glycemic Control and Clinical Parameters on Tibial Nerve Conduction Latency in Diabetic Peripheral Neuropathy

Investigation of the Effects of Glycemic Control and Clinical Parameters on Tibial Nerve Conduction Latency in Individuals With Diabetic Peripheral Neuropathy


Sponsor

Fenerbahce University

Enrollment

50 participants

Start Date

Apr 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This observational cross-sectional study aims to investigate the effects of glycemic control and clinical parameters on tibial nerve conduction latency in individuals with diabetic peripheral neuropathy. Adults aged 45 to 76 years with diabetic peripheral neuropathy will be evaluated at a neurology and clinical neurophysiology clinic. Data collection will include demographic and clinical characteristics, diabetes type and duration, fasting blood glucose, and HbA1c values obtained from routine clinical records. Participants will also be assessed using the Michigan Neuropathy Screening Instrument (MNSI), including both the questionnaire and physical examination components. Nerve conduction studies will be performed using standard electromyography procedures, and tibial nerve conduction latency will be recorded. The study will examine the relationship between tibial nerve conduction latency and glycemic control parameters, neuropathy screening scores, and diabetes duration. The findings may help improve early identification and clinical evaluation of diabetic peripheral neuropathy.


Eligibility

Min Age: 45 YearsMax Age: 76 Years

Inclusion Criteria2

  • Participants aged 45 to 76 years
  • Diagnosis of diabetes-related neuropathy based on laboratory tests, clinical findings, and nerve conduction test (NCT) results

Exclusion Criteria7

  • History of autoimmune disease, cerebrovascular disease, or chronic infectious disease
  • Diagnosis of cancer or a history of chemotherapy and/or radiotherapy
  • Radicular neuropathy
  • Chronic kidney failure or liver failure
  • Alcoholism or other substance dependence
  • Mental or physical disability (including blindness)
  • Inability to speak Turkish

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fenerbahçe University

Istanbul, Ataşehir, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07525882


Related Trials